Healthy habits lead to a happy life
Brain cancer
Brain cancer, also known as brain tumor or malignant brain neoplasm, refers to the abnormal growth of cells within the brain. These tumors can arise from the brain tissue itself (primary brain tumors) or spread from cancerous cells in other parts of the body (secondary or metastatic brain tumors).
Types of Brain Cancer:
There are several types of brain cancer, categorized based on the cells from which they originate. The main types of brain cancer include:
Gliomas are the most frequent type of brain tumor, and they develop from glial cells, which nourish and protect nerve cells. They can happen in many areas of the brain and spinal cord.
Glioma subtypes that are common include:
​
Astrocytomas are tumors that arise from astrocytes and can be classified as low-grade (slow-growing) or high-grade (fast-growing).
Oligodendrogliomas: These tumors develop from oligodendrocytes, which produce the myelin sheath that coats nerve fibers.
Ependymomas form in the ependymal cells that line the ventricles (fluid-filled cavities) of the brain and the spinal cord's center.
Meningiomas arise from the meninges, which are the protective membranes that coat the brain and spinal cord. The majority of meningiomas are benign, however, some are cancerous. They frequently grow slowly and can appear in a variety of sites within the skull.
Pituitary adenomas are tumors that form in the pituitary gland, a tiny organ at the base of the brain. Pituitary adenomas are normally benign and emerge from hormone-producing glandular cells. They can interfere with hormone production and induce hormonal abnormalities.
Medulloblastomas are malignant brain tumors that typically affect youngsters. They grow in the cerebellum, which is in charge of coordination and balance. Medulloblastomas have the potential to spread to other regions of the central nervous system.
Schwannomas: Schwannomas, also known as acoustic neuromas, develop from Schwann cells, which cover and support the neurons important for hearing and balance. These tumors are most commonly found around the ear, along the vestibulocochlear nerve.
Craniopharyngiomas are rare tumors that originate near the pituitary gland and often affect children and young adults. They are derived from Rathke's pouch, a tissue in the developing embryo.
Primary CNS lymphomas are tumors that develop in the brain or spinal cord from lymphocytes, a kind of white blood cell. They are usually aggressive and can infect those with compromised immune systems, such as those with HIV/AIDS or on immunosuppressive medication.
Causes:
The exact causes of brain cancer are often not fully understood. However, several factors have been identified as potential contributors to the development of brain cancer.
These factors include:
Certain gene mutations may be inherited by some people, increasing their risk of getting brain cancer. Neurofibromatosis, Li-Fraumeni syndrome, tuberous sclerosis, and von Hippel-Lindau disease have all been linked to an increased incidence of brain tumors.
Ionizing radiation exposure: High-dose radiation exposure, such as that received during radiation therapy for previous head or neck cancers, has been related to an increased risk of developing brain tumors. Occupational radiation exposure, such as that experienced by nuclear industry personnel, may also play a role.
A close family with a history of brain cancer, such as a parent or sibling, may modestly raise an individual's risk of having the disease. It is vital to remember that most incidences of brain cancer are not caused by a family history of the disease.
Age: Although brain tumors can arise at any age, particular forms are more common at certain periods of life. Medulloblastomas, for example, are more common in youngsters, whereas gliomas and meningiomas are more common in older adults.
Chemical exposure: Occupational exposure to some chemicals, such as vinyl chloride, formaldehyde, and insecticides, has been proposed as a risk factor for brain cancer. However, the data linking individual chemicals to brain cancer is inadequate, necessitating further investigation.
Individuals with weaker immune systems, such as those with HIV/AIDS or those taking immunosuppressive therapy after organ transplantation, may be more likely to acquire specific forms of brain tumors, such as primary CNS lymphomas.
Symptoms:
Brain cancer symptoms might vary depending on factors such as tumor size, location, and rate of growth. It should be noted that these symptoms are not limited to brain cancer and can be caused by a variety of different illnesses. However, if you have persistent or increasing symptoms, you should seek the advice of a healthcare expert.
Common signs of brain cancer include:
Headaches: Headaches that are persistent or recurring, especially if they are severe or intensify with time, can be a sign of brain cancer. Headaches may be more severe in the morning or when you first get up, and they may be accompanied by nausea or vomiting.
Seizures are a common sign of brain tumors. Convulsions, involuntary movements, or an abrupt change in consciousness or behavior are all possible symptoms. Seizures can be mild or severe, and they can occur frequently or infrequently.
Changes in cognition and neurological abilities: Brain tumours can impair cognition and neurological abilities. Symptoms could include:
-
Memory issues
-
Difficulty concentrating or clearly thinking
-
Behavior or personality changes
-
Speech slurring or trouble finding the proper words
-
Weakness or numbness in the limbs, usually on one side of the body; issues with coordination and balance
-
Changes in vision or hearing, such as impaired vision or hearing loss
Nausea and vomiting: Severe nausea and vomiting, especially if unrelated to other digestive difficulties, may be symptoms of brain cancer. Other markers of elevated intracranial pressure, such as headaches, may accompany these symptoms.
Fatigue and weakness: Brain cancer can cause generalized fatigue, weakness, or a lack of vitality. Rest and sleep may not help these issues.
Sensory perception changes: Brain tumours can alter sensory perception, resulting in symptoms such as.
Vision changes, such as hazy or double vision
Tinnitus (difficulties hearing or ringing in the ears)
Sense of smell or taste loss
Diagnosis:
The diagnosis of brain cancer involves a combination of medical history assessment, neurological examination, and various diagnostic tests.
Medical history and physical examination: The healthcare expert will begin by taking a full medical history, which will include a discussion of your symptoms, the duration of their occurrence, and any relevant risk factors. A neurological examination will also be performed to examine your reflexes, coordination, strength, and sensory function.
Imaging tests:
-
Magnetic Resonance Imaging (MRI): This imaging technique uses powerful magnets and radio waves to create detailed images of the brain. It provides a clear visualization of the brain structures and helps identify any abnormal growths or tumors.
-
Computed Tomography (CT) scan: CT scans use X-rays to create cross-sectional images of the brain. They can provide information about the size, shape, and location of brain tumors.
-
Biopsy: A biopsy is the definitive method to confirm the presence of cancerous cells in the brain. It involves the removal of a small sample of tissue from the tumor for examination under a microscope. A biopsy can be obtained through various techniques, including.
-
Stereotactic biopsy: A needle is guided to the tumor location using imaging guidance, such as MRI or CT scans.
-
Craniotomy: A surgical procedure in which a part of the skull is temporarily removed to access the tumor and obtain a tissue sample.
-
Laboratory tests: The biopsy sample will be sent to a pathology laboratory, where it will be analyzed by a pathologist. The pathologist examines the cells under a microscope to determine the type and grade of the tumor.
-
Additional tests: Depending on the specific case, additional tests may be performed to gather more information about the tumor and its characteristics. These tests may include.
-
Molecular testing: Genetic or molecular analysis of the tumor cells to identify specific genetic mutations or biomarkers that can guide treatment decisions.
-
Cerebrospinal fluid analysis: If there is suspicion of cancer spreading to the central nervous system, a sample of cerebrospinal fluid may be collected for analysis.
-
Neurocognitive testing: This assessment evaluates cognitive function, memory, and other neurological abilities to establish a baseline and monitor changes throughout the treatment process.
Following confirmation of the diagnosis, more tests may be performed to assess the stage of the cancer, which aids in developing a suitable treatment strategy. The stage of brain cancer is determined by characteristics such as tumour size, location, grade, and if cancer has spread to other parts of the brain or body.
Treatment:
The kind, location, size, grade, and stage of the tumor, as well as the patient's overall health and preferences, all influence brain cancer treatment. A multidisciplinary team of healthcare professionals will collaborate to design an individualized treatment plan, including neurosurgeons, oncologists, radiation oncologists, and other specialists.
When possible, surgical excision of the tumor is frequently the first-line treatment. The goal is to remove as much of the tumor as feasible while protecting healthy brain tissue. Due to the tumor's location or connection with important brain structures, total removal may not be possible in some circumstances. A partial resection or biopsy may be performed in such cases to acquire tissue for diagnosis and to reduce symptoms.
Radiation therapy: Radiation therapy kills cancer cells or shrinks tumors by using high-energy X-rays or other radiation sources. It is frequently used following surgery to target any leftover cancer cells, or as the primary treatment when surgery is not an option. Radiation therapy can be administered either externally (external beam radiation) or internally (brachytherapy) by inserting radioactive material near the tumor.
Chemotherapy is the employment of anti-cancer medications to either eliminate or inhibit the growth of cancer cells. It can be taken orally or intravenously. Chemotherapy may be used as the primary treatment for brain cancer tumors that are not responsive to surgery or radiation therapy. It can also be combined with other treatments.
Targeted therapy: Medication that particularly targets genetic mutations or other distinctive characteristics of cancer cells is used in targeted therapy. These medications work by interfering with certain chemicals involved in cancer cell growth and dissemination. Targeted therapy is very useful when specific genetic changes in tumour cells are discovered.
Immunotherapy works by boosting the immune system of the body to recognize and fight cancer cells. Certain kinds of brain cancer, such as primary CNS lymphomas, can benefit from it. Immunotherapy medications can help boost the immune system's response to cancer cells.
Supportive care: For people with brain cancer, supportive care is critical for controlling symptoms and increasing quality of life. Pain management, anti-nausea drugs, physical therapy, occupational therapy, and psychological support are all part of it.
Brain cancer treatment strategies are highly individualized, with different combinations of treatments utilized depending on the precise characteristics of the tumor and the patient's overall condition. When determining the most appropriate treatment option, the healthcare team will examine aspects such as the tumor kind, stage, and location, as well as the patient's age, general health, and personal preferences.
Prognosis:
The prognosis for brain cancer varies greatly based on various factors, including the tumor's form, grade, stage, location, and size, as well as the patient's age and overall condition. Other factors, such as the tumor's genetic makeup and reaction to treatment, can also influence the prognosis. It is vital to emphasize that each situation is unique, and providing a reliable prognosis without particular individual information is difficult.
Survival rates: Survival rates are statistical estimates that show how persons with brain cancer are likely to fare over a given time period. They cannot, however, anticipate the outcome of every given instance. Five-year relative survival rates, which represent the percentage of persons who are still living five years following diagnosis, are frequently used to categorize survival rates. It's crucial to note that survival rates might vary greatly depending on the type of tumor and other circumstances.
Tumour kind and grade: The prognosis of various types of brain tumours varies. Some low-grade tumours, such as pilocytic astrocytomas, have a better prognosis, whereas high-grade tumours, such as glioblastomas, have a worse prognosis.
Tumour location and size: The tumor's location and size can have an impact on prognosis. Tumours in specific parts of the brain may be more difficult to remove surgically or may cause more severe symptoms. Furthermore, larger tumours may be more difficult to entirely remove and are more likely to return.
Treatment reaction: Treatment response, which includes surgery, radiation therapy, chemotherapy, and targeted therapy, can have a major impact on prognosis. Some tumours may react well to treatment and have a favorable result, whilst others may be resistant to treatment or relapse after initial treatment.
Age and overall health: Younger patients, as well as those in better overall health, have a better prognosis. Age-related factors, such as treatment tolerance, can have an impact on outcomes.
Specific genetic alterations or molecular properties of the tumour can influence prognosis and therapy response. Some genetic changes may be linked to better or worse outcomes, or they may guide the use of targeted medicines.
Disclaimer: This article is meant for informational purposes only and must not be considered a substitute for advice provided by qualified medical professionals.